1. Home
  2. HLXC vs LUCD Comparison

HLXC vs LUCD Comparison

Compare HLXC & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HLXC

Helix Acquisition Corp. III Class A Ordinary Shares

N/A

Current Price

$10.16

Market Cap

227.2M

Sector

N/A

ML Signal

N/A

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

HOLD

Current Price

$1.07

Market Cap

190.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLXC
LUCD
Founded
2025
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
227.2M
190.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HLXC
LUCD
Price
$10.16
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
11.9K
807.0K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$4,346,000.00
Revenue This Year
N/A
$115.58
Revenue Next Year
N/A
$130.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.00
52 Week Low
$10.11
$0.95
52 Week High
$10.35
$1.70

Technical Indicators

Market Signals
Indicator
HLXC
LUCD
Relative Strength Index (RSI) 38.32 36.59
Support Level $10.13 $1.02
Resistance Level $10.31 $1.14
Average True Range (ATR) 0.09 0.09
MACD -0.01 -0.02
Stochastic Oscillator 22.73 2.54

Price Performance

Historical Comparison
HLXC
LUCD

About HLXC Helix Acquisition Corp. III Class A Ordinary Shares

Helix Acquisition Corp III is a blank check company.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: